COVID-19 Treatment (Patented Rx Technology)

• In a Phase III Clinical Trial in Miami, active COVID-19 Infected Patients showed a reduction of viral titers with N115 that were reduced by over 1.2 logs, from 100,000 viruses to under 9,000 by day 6.4 days vs 10.3 days for untreated covid infected patients, which means our N115 Nasal Spray was very effective in reducing the symptoms, coughing/sneezing, fatigue, and preventing the spread of COVID-19.